In prostate cancer, in addition to the relevance of the prostate-specific antigen (PSA) value for diagnosis [1], the lymph node (LN) status is a relevant prognostic factor for the oncological outcome, as well as for planning adjuvant therapy [2]. This evidence concerns the gene KLK3 and prostate cancer.